Christoffer Rosenblad
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Christoffer Rosenblad is currently Chief Executive Officer at Xvivo Perfusion AB since 2022, Director at Bentley Endovascular Group AB, and Independent Director at Sedana Medical AB since 2020.
Formerly, Mr. Rosenblad worked as Controller at Ciba Vision Nordic AB. Education includes a graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
XVIVO PERFUSION AB 0,17% | 29-07-2025 | 53.523 ( 0,17% ) | 2 M $ | 31-05-2026 |
SEDANA MEDICAL AB 0,02% | 31-12-2024 | 20.000 ( 0,02% ) | 20 383 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| XVIVO PERFUSION AB | Algemeen Directeur | 27-09-2022 |
| SEDANA MEDICAL AB | Directeur/Bestuurslid | 19-05-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
Ciba Vision Nordic AB | Comptroller/Controller/Auditor | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba Vision Nordic AB | |
Xvivo Perfusion AB
Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
Sedana Medical AB
Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau